22-27751055-CA-C
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_002430.3(MN1):c.3822del(p.Gly1275AlafsTer45) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Genomes: not found (cov: 32)
Consequence
MN1
NM_002430.3 frameshift
NM_002430.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -1.27
Genes affected
MN1 (HGNC:7180): (MN1 proto-oncogene, transcriptional regulator) Meningioma 1 (MN1) contains two sets of CAG repeats. It is disrupted by a balanced translocation (4;22) in a meningioma, and its inactivation may contribute to meningioma 32 pathogenesis. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. There are 6 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 22-27751055-CA-C is Pathogenic according to our data. Variant chr22-27751055-CA-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 2443066.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MN1 | NM_002430.3 | c.3822del | p.Gly1275AlafsTer45 | frameshift_variant | 2/2 | ENST00000302326.5 | NP_002421.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MN1 | ENST00000302326.5 | c.3822del | p.Gly1275AlafsTer45 | frameshift_variant | 2/2 | 1 | NM_002430.3 | ENSP00000304956 | P1 | |
MN1 | ENST00000497225.1 | n.178del | non_coding_transcript_exon_variant | 2/2 | 1 | |||||
MN1 | ENST00000703102.1 | n.347del | non_coding_transcript_exon_variant | 2/2 | ||||||
MN1 | ENST00000424656.1 | c.175del | p.Gly60AlafsTer45 | frameshift_variant, NMD_transcript_variant | 2/3 | 5 | ENSP00000397805 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
CEBALID syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Johns Hopkins Genomics, Johns Hopkins University | Nov 03, 2022 | This MN1 variant is absent from a large population dataset and has not been reported in ClinVar nor the literature, to our knowledge. This frameshift variant is predicted to lead to a premature termination signal within the last exon of the gene, likely escaping nonsense-mediated decay and resulting in a truncated protein product. This variant clusters with other reported MN1 truncating variants identified in individuals with MCTT syndrome. Parental specimens were unavailable to confirm that this variant is de novo. We consider c.3822delT (p.Gly1275fs) to be likely pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.